Mark Baillet joins S-cubed Biometrics
This article was originally published in Scrip
Mark Baillet has joined S-cubed Biometrics, a consultancy company focused on project management, regulatory affairs, quality assurance and biometrics, as managing director. He will lead and provide services in the statistics, SAS programming and data management consultancy business. Mr Baillet was most recently vice-president of data sciences at SRA Global Clinical Development.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.